Healthcare
James M. Gower
Chairman and CEO, Rigel Pharmaceuticals, Inc.From 1992 to March 1996 James was President and Chief Executive Officer of Tularik, Inc., a biotechnology company developing small-molecule drugs regulating gene expression. Previously, he was a Senior Vice President at Genentech, where he had a lead responsibility for business development and sales and marketing functions, and established and managed Genentech’s foreign operations in Canada and Japan. He also served as president of Genentech Development Corporation and currently serves as director of the board of Cell Genesys, Inc. He holds an MBA from the University of Tennessee.
